Network Immunology

Network Immunology is a pioneering biotech firm headquartered in Canada, specifically Vancouver. Established in 2003, the company is crafting breakthrough solutions for the health and wellness sector.

At the heart of its innovation is AbstimX™, a transformative immunotherapeutic platform designed to recalibrate and stabilize overactive immune systems, offering long-term relief. Early-stage results from pre-clinical studies highlight AbstimX™'s efficacy and safety profile in tackling a spectrum of inflammatory diseases, positioning it as a potential game-changer against chronic allergies and autoimmune conditions.

With the mission to significantly reduce suffering from inflammatory diseases worldwide, Network Immunology aims to ensure universal access to AbstimX™. Their strategy centers on developing and commercializing novel immunotherapeutics alongside associated intellectual property, and they seek investors to join them in this mission to bring AbstimX™ to market.